Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction to: The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study.
Ishiba H, Sumida Y, Tanaka S, Yoneda M, Hyogo H, Ono M, Fujii H, Eguchi Y, Suzuki Y, Yoneda M, Takahashi H, Nakahara T, Seko Y, Mori K, Kanemasa K, Shimada K, Imai S, Imajo K, Kawaguchi T, Nakajima A, Chayama K, Saibara T, Shima T, Fujimoto K, Okanoue T, Itoh Y; Japan Study Group of Non-Alcoholic Fatty Liver Disease (JSG-NAFLD). Ishiba H, et al. Among authors: nakajima a. J Gastroenterol. 2018 Nov;53(11):1225. doi: 10.1007/s00535-018-1478-7. J Gastroenterol. 2018. PMID: 29802457
Comparison of the effect on intragastric pH of a single dose of omeprazole or rabeprazole: which is suitable for on-demand therapy?
Inamori M, Togawa J, Takahashi K, Yoneda M, Fujisawa N, Iwasaki T, Ozawa Y, Kikuchi T, Muramatsu K, Chiguchi G, Matsumoto S, Kawamura H, Abe Y, Kirikoshi H, Kobayashi N, Sakaguchi T, Takamura T, Nakajima A, Ueno N, Sekihara H. Inamori M, et al. Among authors: nakajima a. J Gastroenterol Hepatol. 2003 Sep;18(9):1034-8. doi: 10.1046/j.1440-1746.2003.03126.x. J Gastroenterol Hepatol. 2003. PMID: 12911659 Clinical Trial.
Efficacy of a triple therapy with rabeprazole, amoxicillin, and faropenem as second-line treatment after failure of initial Helicobacter pylori eradication therapy.
Togawa J, Inamori M, Fujisawa N, Takahashi H, Yoneda M, Kawamura H, Abe Y, Kirikoshi H, Kobayashi N, Sakaguchi T, Takamura T, Nakajima A, Ueno N, Sekihara H. Togawa J, et al. Among authors: nakajima a. Hepatogastroenterology. 2005 Mar-Apr;52(62):645-8. Hepatogastroenterology. 2005. PMID: 15816496 Clinical Trial.
[The roles of PPARs in digestive diseases].
Nakajima A, Yoneda M, Takahashi H, Fujisawa N, Wada K. Nakajima A, et al. Nihon Rinsho. 2005 Apr;63(4):665-71. Nihon Rinsho. 2005. PMID: 15828235 Review. Japanese.
[PPARgamma and colon cancer].
Fujisawa N, Fujisawa T, Fujita K, Takahashi H, Nakajima A. Fujisawa N, et al. Among authors: nakajima a. Nihon Shokakibyo Gakkai Zasshi. 2005 Aug;102(8):994-1003. Nihon Shokakibyo Gakkai Zasshi. 2005. PMID: 16124705 Review. Japanese. No abstract available.
2,137 results